NurExone Biologic Inc. has seen a notable decline in its stock price this week, raising questions among investors.
This week, NurExone Biologic Inc. (NRX.V) experienced a significant downturn, closing at C$0.60, down 7.69% on the day and for the week. Despite a more favorable performance over the past month, the current price action has caught the attention of retail investors looking for insights into the stock's trajectory.
Investor takeaway: With no major news to explain the recent price drop, investors may want to consider the technical indicators and broader market conditions before making any decisions.
Advertisement
NurExone Biologic Inc.
NRX.V
NRX.V
NurExone Biologic Inc.
WealthAwesomeMarket cap
$55.23M
52W high
$1.12
52W low
$0.43
1W change
-7.69%
Beta
0.45
Analyst Price Targets
Based on analyst covering NRX · as of Sep 17, 2026
Wall Street analysts forecast NRX stock price to rise 315.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.49
+315.2% Upside
Current Price
C$0.60
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NRX's historical volatility
30-Day Vol
118.4%
Annualized
90-Day Vol
82.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.82
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.73 | C$0.49 – C$1.10 |
| 60 trading days | C$0.78 | C$0.44 – C$1.38 |
| 90 trading days | C$0.82 | C$0.41 – C$1.67 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
NurExone's Price Action Shows a 7.69% Decline This Week
Despite the recent decline, NurExone's stock has gained 26.32% over the past month, indicating potential volatility and investor interest.
Bull case
Analysts remain optimistic about NurExone, suggesting that the stock has significant upside potential from its current levels.
Bear case
The stock's performance this week, along with its low trading volume compared to average levels, may signal caution among investors.
Recent Price Action
Advertisement
NurExone Biologic Inc. (NRX.V) has faced a challenging week, with its stock price decreasing by 7.69% on both Friday and over the week, closing at C$0.60. This decline contrasts sharply with the stock's performance over the past month, where it has increased by 26.32%. Investors are now closely watching the stock's movement as it navigates these fluctuations.
Technical Picture
The technical indicators for NurExone Biologic Inc. reveal a mixed picture. The stock is currently trading above its 50-day moving average of C$0.54, which is a positive sign at +11.5%. However, it is slightly below its 200-day moving average of C$0.61, showing a -1.0% deviation. The stock's 52-week range is between C$0.43 and C$1.12, indicating it is currently at 24% of its range. With a beta of 0.45, the stock is less volatile than the broader market, which may appeal to risk-averse investors.
Volume Analysis
The trading volume for NurExone this week was 23,002 shares, significantly lower than the 20-day average volume of 37,962 shares, resulting in a volume ratio of 0.45x. This lower trading volume could suggest reduced investor interest or caution among traders, which may contribute to the stock's recent price decline.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
